News – Page 441 – Endpoints News

Manufacturing roundup: Symeres buys CRO in New Jersey; Cambrex invests $16M+ in Minnesota and Iowa facilities

3 years ago

GSK puts a 'force majeure’ on the manufacturing of a pain medicine in Pakistan

3 years ago

Broad and MIT scientists repurpose hot RNA editing tech as ‘radar’ with uses in cancer and brain research

3 years ago

Alnylam blames the Inflation Reduction Act for a PhIII cut — would it have sold enough for negotiations?

3 years ago

Plant-based Covid-19 vaccine developer Medicago laying off 60+ at North Carolina plant

3 years ago

2seventy inks T cell partnership with Chinese biotech; Antisense drug causes brain side effect — report

3 years ago

AstraZeneca's Ultomiris reduces episode occurrence in NMOSD, meeting primary and secondary endpoints

3 years ago

Eli Lilly commits $92M+ to Purdue University to establish pharma manufacturing scholarship program

3 years ago

Takeda bumps Entyvio peak sales, lays out dengue vaccine plans and celiac pipeline in latest earnings call

3 years ago

Fujifilm Diosynth breaks ground on $300M expansion project in Texas

3 years ago

Moderna nearing deal with US government to develop Ebola vaccines — report

3 years ago

‘Unlikely to transform patient care’: GSK punts top late-stage drug after PhIII data disappoint

3 years ago

Adcomm offers mixed vote, recommends GSK's kidney disease drug in just one patient population

3 years ago

'Beginning of a broader loss': Pharma execs call regulators and legislators to action four months post-Roe

3 years ago

Indian site for Jubilant Generics lands Form 483 for QC issues

3 years ago

Emergency clinical research: Biden's OSTP wants to settle 'key terms' in advance of trials

3 years ago

As Revlimid faces more competition, Bristol Myers' goal is to 'grow the company'

3 years ago

Aurobindo Pharma’s US branch issues a recall of a generic medicine

3 years ago

Sanofi, Regeneron take Dupixent to Broadway with latest actor celebrity spokesperson

3 years ago

A one-time pop singer with mega-money star connections hatches a $100M plan to invest in ‘contrarian’ biotech ...

3 years ago

Viatris and others become latest targets of Novartis' Entresto patent litigation

3 years ago

Using herpes virus vectors, Paul Peter Tak and Carl June team up to solve the CAR-T solid tumor challenge

3 years ago

Having cemented its name in long-read sequencing, PacBio takes a stab at Illumina with new short-read tech

3 years ago

Vaxcyte's data lead to $600M haul, while Taysha looks to raise cash after Astellas deal

3 years ago

First page Previous page 438 439 440441442 443 444 Next page Last page